Mumbai: GlaxoSmithKline Pharmaceuticals Limited has announced the appointment of Chinmay Sharma, Executive Vice President - ...

London: GSK plc has announced the New Drug Application (NDA) for linerixibat, an investigational targeted inhibitor of the ...

The FTSE 100 index closed up 12.76 points, 0.2%, at 8,787.02. The FTSE 250 ended down 11.19 points, 0.1%, at 21,017.78, and the AIM All-Share closed up 5.38 points, 0.7%, at 753.51.

The FTSE 100 index closed up 12.76 points, 0.2%, at 8,787.02. The FTSE 250 ended down 11.19 points, 0.1%, at 21,017.78, and ...

Or, perhaps more diplomatically, an 'escalate to de-escalate' strategy." He continued: "Every tariff threat takes another chunk out of the US' institutional credibility, and provides international ...

According to J&J, Akeega is the first PARP inhibitor combination that’s proven effective treating earlier-stage prostate ...

EUROPE’S benchmark stock index ended little changed on Tuesday, as investors ceded ground under the dual pressure of ...

The FDA has already approved PARP inhibitors in certain patients with metastatic castration-resistant prostate cancer (mCRPC) ...

Johnson & Johnson announced today first results from the Phase 3, randomized, double-blind, placebo-controlled AMPLITUDE study evaluating the combination of niraparib and abiraterone acetate plus ...

Thames Water today said private equity giant KKR has ended its involvement in a potential fundraising plan for the troubled ...

Stocks in Germany rose 0.7%, while those in France gained 0.3%. London’s FTSE edged up 0.1%, while Spain’s IBEX dropped 0.5%. On the macroeconomic front, cooling inflation across the bloc — now ...

London stocks ended Tuesday's session on a mixed note, with strength in some sectors offset by weakness among mining stocks ...